We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

179 hedge funds and large institutions have $888M invested in Ariad Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 22

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

36% more capital invested

Capital invested by funds: $655M → $888M (+$233M)

6% more funds holding

Funds holding: 169 → 179 (+10)

2% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 50

8% less call options, than puts

Call options by funds: $32M | Put options by funds: $34.7M

Holders
179
Holders Change
+10
Holders Change %
+5.92%
% of All Funds
4.77%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
34
Increased
49
Reduced
50
Closed
22
Calls
$32M
Puts
$34.7M
Net Calls
-$2.74M
Net Calls Change
+$3.27M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$52M
2
PI
Putnam Investments
Massachusetts
+$18.8M
3
PC
PointState Capital
New York
+$10.3M
4
CCM
Camber Capital Management
Massachusetts
+$9.38M
5
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
+$8.63M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$12.8M
2
Millennium Management
Millennium Management
New York
-$8.89M
3
DFO
Duquesne Family Office
New York
-$8.88M
4
JP Morgan Chase
JP Morgan Chase
New York
-$6.85M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
176
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$724 -$14.9K -2,390 -2%
SM
177
Sabby Management
Florida
$439 -$867K -138,557 -68%
HM
178
HealthCor Management
New York
– -$12.8M -2,365,000 Closed
DFO
179
Duquesne Family Office
New York
– -$8.88M -1,645,000 Closed
Nomura Holdings
180
Nomura Holdings
Japan
– -$3.82M -694,854 Closed
VAM
181
Visium Asset Management
New York
– -$1.02M -188,748 Closed
SFM
182
Soros Fund Management
New York
– -$810K -150,000 Closed
ARTA
183
A.R.T. Advisors
New York
– -$651K -120,670 Closed
6CM
184
683 Capital Management
New York
– -$540K -100,000 Closed
VKH
185
Virtu KCG Holdings
New York
– -$347K -64,282 Closed
AL
186
Airain Ltd
Guernsey
– -$309K -57,246 Closed
QSS
187
Quantitative Systematic Strategies
Florida
– -$293K -52,083 Closed
Nomura Asset Management
188
Nomura Asset Management
Japan
– -$270K -50,000 Closed
William Blair & Company
189
William Blair & Company
Illinois
– -$236K -43,685 Closed
QC
190
QCM Cayman
Texas
– -$209K -38,614 Closed
QT
191
Quantbot Technologies
New York
– -$204K -37,896 Closed
SEC
192
Seven Eight Capital
New York
– -$136K -21,751 -100%
SCM
193
Stevens Capital Management
Pennsylvania
– -$64K -11,890 Closed
BNP Paribas Financial Markets
194
BNP Paribas Financial Markets
France
– -$53.3K -9,878 Closed
SO
195
STRS Ohio
Ohio
– -$22K -4,000 Closed
OSNBOA
196
Old Second National Bank of Aurora
Illinois
– -$5K -1,000 Closed
TDC
197
Thompson Davis & Co
Virginia
– -$3K -500 Closed
TCM
198
Tradewinds Capital Management
Washington
– -$2K -300 Closed
LWA
199
Lenox Wealth Advisors
New York
– -$1K -142 Closed
PIM
200
Parasol Investment Management
Illinois
– -$1K -133 Closed
4 5 6 7
8

ARIA Hedge Fund Activity: Q4 2014 in Review

179 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q4 2014, worth a combined $888M — up 36% from $655M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ARIA positions and 22 closed out — a net gain of 12 holders — while 49 added to existing stakes and 50 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $52M. The largest seller was HealthCor Management, exiting entirely with an estimated $12.8M sold.

  • 179 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q4 2014, up from 169 in Q3 2014.
  • Funds reported $888M of Ariad Pharmaceuticals Inc stock for Q4 2014, up 36% quarter-over-quarter.
  • 34 funds opened new Ariad Pharmaceuticals Inc positions in Q4 2014 and 22 closed out, a net change of +12 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q4 2014 was Westfield Capital Management, an estimated $52M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q4 2014 was HealthCor Management, an estimated $12.8M sold.

Based on aggregated 13F filings for Q4 2014.